 |
PDBsum entry 3iph
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
P38alpha mitogen-Activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
|
 |
|
Authors
|
 |
N.M.Aston,
P.Bamborough,
J.B.Buckton,
C.D.Edwards,
D.S.Holmes,
K.L.Jones,
V.K.Patel,
P.A.Smee,
D.O.Somers,
G.Vitulli,
A.L.Walker.
|
 |
|
Ref.
|
 |
J Med Chem, 2009,
52,
6257-6269.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
p38alpha MAP kinase is a key anti-inflammatory target for rheumatoid arthritis,
influencing biosynthesis of pro-inflammatory cytokines TNFalpha and IL-1beta at
a translational and transcriptional level. In this paper, we describe how we
have optimized a series of novel p38alpha/beta inhibitors using crystal
structures of our inhibitors bound to p38alpha, classical medicinal chemistry,
and modeling of virtual libraries to derive a molecule suitable for progression
into clinical development.
|
 |
|
|
|
|
 |